MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

LY2828360

CAS No. : 1231220-79-3

MCE 站：LY2828360

产品活性：LY2828360 是一个作用缓慢但很有效的 G 蛋白偏倚的大麻素受体 2 (CB₂) 激动剂，能够抑制 cAMP 的积累并激活 ERK1/2 通路。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Cannabinoid Receptor

In Vivo: In WT mice, acute systemic administration of LY2828360 suppresses paclitaxel-induced mechanical and cold allodynia in a dose-dependent manner. LY2828360 produces time-dependent suppressions of paclitaxel-evoked mechanical and cold hypersensitivities and suppression of allodynia is maintained for at least 4.5 h post-injection relative to drug pre-injection levels. At 24 h post-injection, paclitaxel-induced mechanical allodynia has returned to drug pre-injection levels of hypersensitivity. Residual suppression of cold allodynia was absent by 72 h post LY2828360 treatment. Previously chronic administration of LY2828360 blocks the development of tolerance to the antiallodynic effects of morphine in WT but not in CB₂KO mice. Chronic LY2828360 treatment suppresses paclitaxel-induced mechanical and cold allodynia in WT mice but not in CB₂KO mice previously render tolerant to morphine.

相关产品：Drug Repurposing Compound Library  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Clinical Compound Library  |  Clinical Compound Library Plus  |  Anti-COVID-19 Compound Library  |  Drug Repurposing Compound Library Plus  |  Bioactive Compound Library Plus  |  WIN 55,212-2 Mesylate  |  AM251  |  SR144528  |  Rimonabant Hydrochloride  |  JD-5037  |  Taranabant  |  6-Iodopravadoline  |  2-Arachidonoylglycerol  |  Anandamide  |  GW842166X  |  Pregnenolone  |  β-Caryophyllene  |  Bay 59-3074  |  Otenabant  |  (±)-Ibipinabant  |  A-836339  |  CB1 antagonist 2  |  Olivetol  |  N-Oleoyl glycine  |  Olorinab  |  Org 27569  |  VCE-?004.8  |  Yangonin  |  BML-190  |  CB1-IN-1  |  MDA 19

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。